About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our research group is accredited by the Agency for Management of University and Research Grants (AGAUR) in Catalonia, and focuses on two main areas of interest which are related to Solid Organ Transplantation and especially Kidney, and in clinical Nephrology. We tackle these areas from an innovative perspective, both basic-experimental and mechanistic, always with a translational goal. On the one hand, we investigate, develop, and use novel diagnostic and therapeutic technologies to decipher and target main molecular and immune mechanisms of transplant rejection as well as the immune susceptibility to opportunistic infections and malignancies. Also, a main task force of the group is devoted to better understand the main mechanisms involved in certain autoimmune glomerular diseases and idiopathic nephrotic syndrome as well as in diabetic kidney disease, having a specific interest in the role of the renin-angiotensin system. Our ultimate goal is to improve the management and care of patients suffering from kidney diseases as well as their quality of life, reducing associated morbidity and mortality.
PMID: 33777371 Journal: Clinical Kidney Journal Year: 2021 Reference: Clin Kidney J. 2020 May 4;14(3):884-890. doi: 10.1093/ckj/sfaa027. eCollection 2021 Mar. Impact factor: 4.452 Publication type: Paper in international publication Authors: Draibe, Juliana B, Garcia-Carro, Clara, Martinez-Valenzuela, Laura, Agraz, Irene, Fulladosa, Xavier, Bolufer, Monica, Tango, Ariel, Torras, Joan, Soler, Maria Jose et al. DOI: 10.1093/ckj/sfaa027
PMID: 33756067 Journal: AMERICAN JOURNAL OF TRANSPLANTATION Year: 2021 Reference: Am J Transplant. 2021 Jul;21(7):2573-2582. doi: 10.1111/ajt.16579. Epub 2021 Apr 12. Impact factor: 8.086 Publication type: Paper in international publication Authors: Villanego, Florentino, Mazuecos, Auxiliadora, Perez-Flores, Isabel M, Moreso, Francesc, Andres, Amado, Jimenez-Martin, Carlos, Molina, Maria, Canal, Cristina, Sanchez-Camara, Luis A, Zarraga, Sofia et al. DOI: 10.1111/ajt.16579
PMID: 33166580 Journal: KIDNEY INTERNATIONAL Year: 2021 Reference: Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Impact factor: 10.612 Publication type: Paper in international publication Authors: Espinosa, Mario, Egido, Jesus, Segarra, Alfonso, Lambeau, Gerard, Ronco, Pierre, Wetzels, Jack, Praga, Manuel, Plaisier, Emmanuelle, Shabaka, Amir, Romera, Ana et al. DOI: 10.1016/j.kint.2020.10.014
PMID: 33714629 Journal: NEFROLOGIA Year: 2021 Reference: Nefrologia (Engl Ed). 2021 Mar 10. pii: S0211-6995(21)00031-X. doi: 10.1016/j.nefro.2021.01.002. Impact factor: 2.033 Publication type: Paper in national publication Authors: Lopes, Vanessa, Ramos, Carmela, Mendez, Irene, Cao, Mercedes, Dominguez, Fernando, Ortiz, Alberto, Martin-Conde, Maria Luisa, Gutierrez, Maria Jose, Quiroga, Borja, Corchete, Elena et al. DOI: 10.1016/j.nefro.2021.01.002
A study from the Vall d’Hebron Campus demonstrates that the Ex Vivo C5b-9 deposition test is useful for monitoring the activity of the complement system (CS) in patients with aHUS or transplant-associated TMA.
An international study involving the Hospital del Mar Research Institute and VHIR shows that there are substantial differences between men and women in the energy metabolism of of renal tubular cells.
Dr. Conxita Jacobs' research has been awarded in the clinical project category, while Dr. Anna Meseguer's research has been recognised in the basic research category.
